Charles River Laboratories (CRL) Tops Q1 EPS by 12c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mail
Get Alerts CRL Hot Sheet
Price: $376.10 +0.57%
EPS Growth %: +22.2%
Financial Fact:
Amortization of intangibles: 11.83M
Today's EPS Names:
PFBX, GOVB, VABK, More
EPS Growth %: +22.2%
Financial Fact:
Amortization of intangibles: 11.83M
Today's EPS Names:
PFBX, GOVB, VABK, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $2.06, $0.12 better than the analyst estimate of $1.94. Revenue for the quarter came in at $995.8 million versus the consensus estimate of $978.34 million.
GUIDANCE:
Charles River Laboratories sees FY 2026 EPS of $10.80-$11.30, versus the consensus of $11.07.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SPS Commerce (SPSC) Tops Q3 EPS by 16c; Offers Guidance
- BCB Bancorp (BCBP) Tops Q3 EPS by 245c
- Pro-Dex (PDEX) Tops Q1 EPS by 26c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
